BSAC Spring Conference 2020

Into Clinical Practice
- Bridging the gap between science, policy and effective antimicrobial use

A global overview of drug development and effective use through diagnostics, stewardship and shared learning

16-17 March 2020

Queen Elizabeth Conference Centre, Westminster, London

Defeating AMR: The trinity of prevention, preservation & promotion

You will find links to the slide sets below.

MONDAY 12 MARCH

Welcome and Opening Remarks

Professor Dilip Nathwani OBE

KEYNOTE PRESENTATION

Global epidemiology of infectious diseases and AMR and the role of informatics

Professor Michael Osterholm

PLENARY SESSION: HOW CAN VACCINES AND DIAGNOSTICS TO HELP WIN THE BATTLE AGAINST AMR?

Global burden of bacterial infections: the role of vaccines in reducing AMR

Dr David McIntosh

Enabling the adoption of new diagnostics within the UK healthcare system

Dr Fiona Carragher

PLENARY SESSION: PRESERVING ANTIBIOTIC EFFICACY THROUGH EFFECTIVE PRESCRIBING: WHAT CAN WE LEARN FROM STEWARDSHIP IN LMICS?

Stewardship in Kerala, India

Dr Sanjeev Singh

Experiences from Latin America

Dr Gabriel Levy Hara

Stewardship in Africa - challenges and opportunities

Dr Brian Godman

SPONSORED SYMPOSIUMS

Diagnostic testing for point of care C Reactive Protein and how it can guide antibiotic prescribing

Supported by Abbott

BEYOND EMPERICAL THERAPY - Clinical Experiences with Fast Antibiotic Susceptibility Testing

Technology overview - The Accelerate Pheno™ System

Steve Holland

Clinical Experiences of the Accelerate Pheno™ System at an NHS District General Hospital

Dr Claire Thomas

PARALLEL SESSION - Routine and rapid surveillance systems

What surveillance do we have for AMR?

Dr Berit Muller-Peabody

Why is surveillance important after introducing vaccines?

Dr Michael Edelstein

Rapid surveillance in emergency situations: The Zika Experience

Professor Jimmy Whitworth

Legacy planning – what did we learn from Ebola

Dr Timothy Brooks

PARALLEL SESSION - The quiet revolution: the modernisation of laboratories - optimal use of existing diagnostics

Procalcitonin – lessons and limitations

Dr Stephan Harbarth

MALDI-TOF and its impact on patient care

Dr Savita Gossain

Syndromic approaches to infection detection - TaqMan array cards

Dr Martin Curran

PARALLEL SESSION - Successful stewardship across multidisciplinary settings

Alternative models of care: Nurses in antimicrobial stewardship

Jo McEwen

Successful stewardship in hospital settings (HDU and general)

Dr Charles Luyt

Antimicrobial stewardship in long term care facilities (LTCFs)

Dr Elizabeth Beech

PARALLEL SESSION - Global surveillance of resistance & antibiotic prescribing quality

Global Antimicrobial Resistance Surveillance System (GLASS)

Professor Roman Kozlov

Global PPS

Professor Herman Goossens

TUESDAY 13 MARCH

PLENARY SESSION: VACCINES AND DIAGNOSTICS – WHAT DOES THE FUTURE HOLD?

New Vaccines against Epidemic Infectious Diseases

Dr David McIntosh

PARALLEL SESSION - Innovation: Rapid diagnostics and emerging therapies

New for old and emerging treatments - a summary of new agents in development

Professor Alasdair MacGowan

Clinical need for rapid diagnostic tests

Professor Herman Goossens

Skin patch antibiotics - the next big thing?

Professor Ryan Donnelly

Harnessing the host-protein response to distinguish between bacterial and viral infections

Dr Liran Shani

Lefamulin: the potential for one antibiotic rather than two in CABP

Professor Mark Wilcox

PARALLEL SESSION - Next generation Antimicrobial Susceptibility Testing of Bacteria

Rapid susceptibility testing: new phenotypic and non-WGS genotypic approaches

Dr Oskar Ekelund

WGS-based susceptibility testing for TB: from research to service delivery

Professor Grace Smith

Should WGS be used for susceptibility testing of bacteria other than TB?

Dr Matthew Ellington

GARROD LECTURE

Preparing for the Black Swans of resistance

Professor David Livermore

KEYNOTE LECTURE

Progressing the new essential medicines agenda

Professor Celine Pulcini

Reporting Guidelines Workshop

Use of reporting guidelines to design, report and referee antibiotic stewardship studies

Dr Sheldon Stone

PARALLEL SESSION

Latest clinical data and early experience of managing difficult-to-treat Gram-negative infections with a novel β-lactamase inhibitor combination

Supported by Pfizer

PARALLEL SESSION

Current thinking about cephalosporins and CDI & AMR. Can a new cephalosporin help?

Supported by Cardiome

CLOSING PLENARY SESSION - NOVEL GLOBAL EDUCATIONAL OPPORTUNITIES

Delivering open access, high impact-low cost education to all

Professor Dilip Nathwani OBE

Developing a global community of practice

Dr Elizabeth Tayler

Poster abstracts

Top